Statement re. Suspension

AI SummaryClose X

Trading in SkinBioTherapeutics plc ordinary shares has been suspended effective immediately due to the company's failure to announce its interim results for the six months ended 31 December 2025 by the required deadline of 31 March 2026. The company anticipates trading will resume upon the publication of these interim results, which are expected to be released following the conclusion of an ongoing Board investigation and an independent forensic review by FRP Advisory, both of which are progressing and are hoped to be finalized later this month.

Disclaimer*

UK 100

Latest directors dealings